PTC Therapeutics
PTCT
#2794
Rank
โ‚น556.52 B
Marketcap
โ‚น6,932
Share price
-1.18%
Change (1 day)
60.14%
Change (1 year)

Earnings for PTC Therapeutics (PTCT)

Earnings in 2025 (TTM): โ‚น63.20 Billion

According to PTC Therapeutics 's latest financial reports the company's current earnings are โ‚น1.77 Billion. In 2024 the company made an earning of -โ‚น33.33 Billion, an increase over its 2023 earnings that were of -โ‚น63.89 Billion. The earnings displayed on this page are the earnings before interest and taxes or simply EBIT.

Earnings history for PTC Therapeutics from 2012 to 2025

Annual earnings

Year Earnings Change
2025 (TTM) โ‚น63.20 B-289.67%
2024 -โ‚น33.33 Billion-47.84%
2023 -โ‚น63.89 Billion18.49%
2022 -โ‚น53.92 Billion13.34%
2021 -โ‚น47.57 Billion28.64%
2020 -โ‚น36.98 Billion67.94%
2019 -โ‚น22.02 Billion87.28%
2018 -โ‚น11.76 Billion64.95%
2017 -โ‚น7.13 Billion-45.13%
2016 -โ‚น12.99 Billion-16.72%
2015 -โ‚น15.6 Billion72.64%
2014 -โ‚น9.04 Billion90.89%
2013 -โ‚น4.74 Billion96.58%
2012 -โ‚น2.41 Billion

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Novartis
NVS
โ‚น1.506 T 2,115.78%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Vertex Pharmaceuticals
VRTX
โ‚น409.44 B 502.09%๐Ÿ‡บ๐Ÿ‡ธ USA
Xencor
XNCR
-โ‚น12.67 Billion-118.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Sarepta Therapeutics
SRPT
-โ‚น23.15 Billion-134.03%๐Ÿ‡บ๐Ÿ‡ธ USA
Fate Therapeutics
FATE
-โ‚น14.69 Billion-121.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Avidity Biosciences
RNA
-โ‚น50.46 Billion-174.19%๐Ÿ‡บ๐Ÿ‡ธ USA